Section Arrow
ABVC.NASDAQ
- ABVC BioPharma
(Financial Status)
Quotes are at least 15-min delayed:2025/05/13 18:51 EDT
Last
 1.68
+0.32 (+23.53%)
Day High 
1.68 
Prev. Close
1.36 
1-M High
1.42 
Volume 
707.06K 
Bid
1.59
Ask
1.69
Day Low
1.38 
Open
1.38 
1-M Low
0.806 
Market Cap 
22.81M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.16 
20-SMA 1.04 
50-SMA 0.88 
52-W High 1.42 
52-W Low 0.4 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.19/-0.46
Enterprise Value
23.05M
Balance Sheet
Book Value Per Share
0.34
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
509.59K
Operating Revenue Per Share
0.05
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PLRZPolyrizon Ltd0.0285-0.3215-91.86%-- 
CNSPCNS Pharmaceuticals Inc.1.36+0.15+12.40%0PE
NCNANuCana plc0.0329-0.0071-17.75%-- 
HCWBHCW Biologics Inc10.05+4.84+92.90%-- 
XLOXilio Therapeutics1.15+0.419+57.32%-- 
Quotes are at least 15-min delayed:2025/05/13 18:51 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.